Liver Cancer - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Liver Cancer > What Your Doctor is Reading About Liver Cancer > General Interest Articles

General Interest Articles

1. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.

Author: El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA;
Institution: Section of Health Services Research, Houston Veterans Affairs Medical Center, Baylor College of Medicine, 2002 Holcombe Boulevard (152), Houston, TX 77030, USA. hasheme@bcm.tmc.edu
Journal: J Hepatol. 2006 Jan;44(1):158-66. Epub 2005 Nov 2.
Abstract URL: Click here to view abstract

2. Clinical characteristics and prognosis of pediatric hepatocellular carcinoma.

Author: Yu SB; Kim HY; Eo H; Won JK; Jung SE; Park KW; Kim WK;
Institution: Department of Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul , 110-744, Korea.
Journal: World J Surg. 2006 Jan;30(1):43-50.
Abstract URL: Click here to view abstract

3. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.

Author: Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C;
Institution: Division of Hepatology and Gene Therapy, School of Medicine, Centro de Investigacion Medica Aplicada, University of Navarra, 31008 Pamplona, Spain.
Journal: Cancer Res. 2006 Feb 1;66(3):1620-9.
Abstract URL: Click here to view abstract

4. Outcome of patients with fibrolamellar hepatocellular carcinoma.

Author: Stipa F; Yoon SS; Liau KH; Fong Y; Jarnagin WR; D'Angelica M; Abou-Alfa G; Blumgart LH; DeMatteo RP;
Institution: Department of Surgery, San Giovanni Hospital, Rome, Italy.
Journal: Cancer. 2006 Mar 15;106(6):1331-8.
Abstract URL: Click here to view abstract

5. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm.

Author: Wakai T; Shirai Y; Suda T; Yokoyama N; Sakata J; Cruz PV; Kawai H; Matsuda Y; Watanabe M; Aoyagi Y; Hatakeyama K;
Institution: Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Niigata 951-8510, Japan.
Journal: World J Gastroenterol. 2006 Jan 28;12(4):546-52.
Abstract URL: Click here to view abstract

6. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents.

Author: Sakakima Y; Hayashi S; Yagi Y; Hayakawa A; Tachibana K; Nakao A;
Institution: Department of Surgery II, Nagoya University School of Medicine, Nagoya 466-8550, Japan. sakakima@med.nagoya-u.ac.jp
Journal: Cancer Gene Ther. 2005 Nov;12(11):884-9.
Abstract URL: Click here to view abstract

7. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival.

Author: Tsukioka G; Kakizaki S; Sohara N; Sato K; Takagi H; Arai H; Abe T; Toyoda M; Katakai K; Kojima A; Yamazaki Y; Otsuka T; Matsuzaki Y; Makita F; Kanda D; Horiuchi K; Hamada T; Kaneko M; Suzuki H; Mori M;
Institution: Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Journal: World J Gastroenterol. 2006 Jan 7;12(1):48-53.
Abstract URL: Click here to view abstract

8. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter.

Author: Huang YH; Wu JC; Chen SC; Chen CH; Chiang JH; Huo TI; Lee PC; Chang FY; Lee SD;
Institution: Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Journal: Aliment Pharmacol Ther. 2006 Jan 1;23(1):129-35.
Abstract URL: Click here to view abstract

9. Brain metastases from hepatocellular carcinoma in US patients.

Author: Seinfeld J; Wagner AS; Kleinschmidt-DeMasters BK;
Institution: Department of Neurosurgery, University of Colorado Health Sciences Center, Denver, CO, USA.
Journal: J Neurooncol. 2006 Jan;76(1):93-8.
Abstract URL: Click here to view abstract

10. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.

Author: Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T;
Institution: Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Journal: Eur J Surg Oncol. 2005 Oct;31(8):882-90.
Abstract URL: Click here to view abstract

11. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients.

Author: Tralhao JG; Dagher I; Lino T; Roudie J; Franco D;
Institution: Service de Chirurgie Generale, Hopital Antoine-Beclere, Faculte de Medecine Paris-Sud, France. jglrt@hotmail.com
Journal: Eur J Surg Oncol. 2007 Aug;33(6):746-51. Epub 2006 Dec 22.
Abstract URL: Click here to view abstract

12. Curing hepatocellular carcinomatosis with biologic therapy and surgery: achieving the impossible?

Author: Thomas MB; Tetzlaff E; Lozano R; Samp L; Butler CE; Gannon C; Hamilton S; Vauthey JN; Abdalla E;
Institution: Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. methomas@mdanderson.org
Journal: J Surg Oncol. 2008 Jan 1;97(1):82-4.
Abstract URL: Click here to view abstract

13. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.

Author: Zhou YM; Yang JM; Wang B; Xu F; Tong Y; Li DQ;
Institution: Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China. zhouyms@yahoo.com.cn
Journal: Hepatobiliary Pancreat Dis Int. 2007 Dec;6(6):656-9.
Abstract URL: Click here to view abstract

14. Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin.

Author: Liu Y; Huang B; Yuan Y; Gong W; Xiao H; Li D; Yu ZR; Wu FH; Zhang GM; Feng ZH;
Institution: Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
Journal: Int J Cancer. 2007 Jul 1;121(1):184-92.
Abstract URL: Click here to view abstract

15. Prognostic index for survival in patients after treatment for primary hepatocellular carcinoma.

Author: Kogo M; Kano A; Kiuchi Y; Mitamura K; Yoneyama K;
Institution: Department of Pathophysiology, Showa University School of Pharmaceutical Sciences, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan. mari-k@pharm.showa-u.ac.jp
Journal: Dig Dis Sci. 2007 Sep;52(9):2444-51. Epub 2007 Apr 10.
Abstract URL: Click here to view abstract

16. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?

Author: Cho SJ; Yoon JH; Hwang SS; Lee HS;
Institution: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Journal: J Gastroenterol Hepatol. 2007 Aug;22(8):1226-31. Epub 2007 May 13.
Abstract URL: Click here to view abstract

17. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century.

Author: Capocaccia R; Sant M; Berrino F; Simonetti A; Santi V; Trevisani F;
Institution: National Centre for Epidemiology, Surveillance and Health Promotion, Department of Cancer Epidemiology, Istituto Superiore di Sanita, Rome, Italy.
Journal: Am J Gastroenterol. 2007 Aug;102(8):1661-70; quiz 1660, 1671. Epub 2007 Jun 6.
Abstract URL: Click here to view abstract

18. Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis.

Author: Yamazaki Y; Kakizaki S; Sohara N; Sato K; Takagi H; Arai H; Abe T; Katakai K; Kojima A; Matsuzaki Y; Mori M;
Institution: Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, 371-8511 Gunma, Japan.
Journal: Dig Dis Sci. 2007 Apr;52(4):1103-7. Epub 2007 Feb 16.
Abstract URL: Click here to view abstract

19. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.

Author: Chok KS; Ng KK; Poon RT; Lam CM; Yuen J; Tso WK; Fan ST;
Institution: Departments of Surgery and Radiology, Centre for the Study of Liver Disease, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong.
Journal: Arch Surg. 2006 Dec;141(12):1231-6.
Abstract URL: Click here to view abstract

20. Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.

Author: Zhou ZH; Liu LM; Chen WW; Men ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL;
Institution: Department of Integrative Chinese and Western Medicine, Fudan University Cancer Hospital, Shanghai 200032, China.
Journal: Br J Radiol. 2007 Mar;80(951):194-201. Epub 2006 Oct 12.
Abstract URL: Click here to view abstract

21. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.

Author: Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M;
Institution: Department of Internal Medicine I, Medical University Clinic, Tubingen, Germany.
Journal: Cancer. 2007 May 15;109(10):2132-41.
Abstract URL: Click here to view abstract

22. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.

Author: Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS;
Institution: Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, Seoul 138-736, Korea. sglee2@amc.seoul.kr
Journal: Br J Surg. 2007 Mar;94(3):320-6.
Abstract URL: Click here to view abstract

23. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.

Author: Sahani DV; Holalkere NS; Mueller PR; Zhu AX;
Institution: Department of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, 55 Fruit St, White 270, Boston, MA 02114, USA. dsahani@partners.org
Journal: Radiology. 2007 Jun;243(3):736-43.
Abstract URL: Click here to view abstract

24. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.

Author: Pekow JR; Bhan AK; Zheng H; Chung RT;
Institution: Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Journal: Cancer. 2007 Jun 15;109(12):2490-6.
Abstract URL: Click here to view abstract

25. Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center.

Author: Ikeda K; Arase Y; Saitoh S; Kobayashi M; Someya T; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Kumada H;
Institution: Department of Gastroenterology, Toranomon Hospital, Toranomon 2-2-2, Minato-ku, Tokyo 105-8470, Japan. ikedakenji@tora.email.ne.jp
Journal: Intervirology. 2006;49(1-2):82-90.
Abstract URL: Click here to view abstract

26. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents.

Author: To KK; Ho YP; Au-Yeung SC; To KK; Ho YP; Au-Yeung SC;
Institution: School of Pharmacy, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
Journal: Anticancer Drugs. 2005 Sep;16(8):825-35.
Abstract URL: Click here to view abstract

27. Management of hepatocellular carcinoma.

Author: Bruix J; Sherman M;
Institution: BCLC Group. Liver Unit. Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain. bruix@ub.edu
Journal: Hepatology. 2005 Nov;42(5):1208-36.

28. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.

Author: Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K;
Institution: First Department of Internal Medicine, Nagasaki University School of Medicine, Sakamoto, Nagasaki, Japan. ntaura-gi@umin.ac.jp
Journal: Clin Gastroenterol Hepatol. 2006 Sep;4(9):1177-83. Epub 2006 Aug 8.
Abstract URL: Click here to view abstract

29. Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival.

Author: Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Sezaki, Hitomi; Hosaka, Tetsuya; Someya, Takashi; Kobayashi, Masahiro; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Kobayashi, Mariko; Kumada, Hiromitsu;
Institution: Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
Journal: Scand J Gastroenterol 2005 Jun;40(6):688-96.
Abstract URL: Click here to view abstract

30. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.

Author: Maluccio, Mary; Covey, Anne M; Gandhi, Ripal; Gonen, Mithat; Getrajdman, George I; Brody, Lynn A; Fong, Yuman; Jarnagin, William; D'Angelica, Michael; Blumgart, Leslie; DeMatteo, Ronald; Brown, Karen T;
Institution: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Journal: J Vasc Interv Radiol 2005 Jul;16(7):955-61.
Abstract URL: Click here to view abstract